Article Versions Notes

Artykov AA, Belov DA, Shipunova VO, Trushina DB, Deyev SM, Dolgikh DA, Kirpichnikov MP, Gasparian ME. Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors. Cancers. 2020; 12(5):1129. https://doi.org/10.3390/cancers12051129

Artykov, Artem A., Dmitry A. Belov, Victoria O. Shipunova, Daria B. Trushina, Sergey M. Deyev, Dmitry A. Dolgikh, Mikhail P. Kirpichnikov, and Marine E. Gasparian. 2020. "Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors" Cancers 12, no. 5: 1129. https://doi.org/10.3390/cancers12051129

Artykov, A. A., Belov, D. A., Shipunova, V. O., Trushina, D. B., Deyev, S. M., Dolgikh, D. A., Kirpichnikov, M. P., & Gasparian, M. E. (2020). Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors. Cancers, 12(5), 1129. https://doi.org/10.3390/cancers12051129